| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/09/2008 | CN100360673C Gene promoters |
| 01/09/2008 | CN100360671C Rhizoma gastrodiae specific DNA molecule labelled series and its application |
| 01/09/2008 | CN100360670C Human MDR1 gene expression regulator screening system and method for screening gene expression regulator |
| 01/09/2008 | CN100360668C Recombinant calmette-Guerin bacillus vaccine for secretion of tumour necrosis factor-alpha and its constructing method |
| 01/09/2008 | CN100360665C I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application |
| 01/09/2008 | CN100360566C Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application |
| 01/09/2008 | CN100360557C S protein of SARS virus, its vaccine and method for screening medicament using it |
| 01/08/2008 | US7317415 System, method, and product for scanning of biological materials employing dual analog integrators |
| 01/08/2008 | US7317216 Ultrasensitive biochemical sensing platform |
| 01/08/2008 | US7317097 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 01/08/2008 | US7317096 Isolated or recombinant nucleic acid sequence encoding an (AAP-1), |
| 01/08/2008 | US7317088 PRO5993 polypeptides |
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317086 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering |
| 01/08/2008 | US7317083 PRO4501 polypeptides |
| 01/08/2008 | US7317081 PRO4371 polypeptides |
| 01/08/2008 | US7317078 Screening compounds for receptor agonist and/or antagonist activities. |
| 01/08/2008 | US7317074 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 01/08/2008 | US7317038 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/08/2008 | US7316931 Mass defect labeling for the determination of oligomer sequences |
| 01/08/2008 | US7316930 Use of vertically stacked photodiodes in a gene chip system |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | US7316912 Tyrosylprotein sulfotransferases and methods of use thereof |
| 01/08/2008 | US7316911 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 01/08/2008 | US7316910 Rapid test for hemolytic streptococcus |
| 01/08/2008 | US7316909 Binding protein as biosensors |
| 01/08/2008 | US7316907 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 01/08/2008 | US7316906 Diagnosing cancer in humans; obtain lymphocytes, monitor preferential cd antigen expression, compare to control, evaluate for cancer |
| 01/08/2008 | US7316905 Method for measurement of hepatitis C virus |
| 01/08/2008 | US7316904 Automated pap screening using optical detection of HPV with or without multispectral imaging |
| 01/08/2008 | US7316903 Detection of nucleic acid sequence variations using phase Mu transposase |
| 01/08/2008 | US7316902 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 01/08/2008 | US7316901 Method of efficiently detecting double-stranded nucleic acid |
| 01/08/2008 | US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 01/08/2008 | US7316899 Apparatus for high speed characterization and discrimination of toxins and/or bacteria in medical, food/beverage and environmental solutions |
| 01/08/2008 | US7316898 Method of determining adenovirus particle concentration |
| 01/08/2008 | US7316897 Isolation of preferential parasitic cells; incubate cells with modulators, monitor cell migration, compare to control, recover preferential parasitic cells |
| 01/08/2008 | US7316779 Filtration system and method for obtaining a cytology layer |
| 01/08/2008 | CA2577229C Electrochemical method |
| 01/08/2008 | CA2346295C Method for determining alkaline phosphatase and eliminating haemoglobin disturbances |
| 01/08/2008 | CA2343713C Use of pex in the treatment of metabolic bone diseases |
| 01/08/2008 | CA2331781C De novo dna cytosine methyltransferase genes, polypeptides and uses thereof |
| 01/08/2008 | CA2324244C Device for analyzing a sample |
| 01/08/2008 | CA2324028C Retroviral packaging cell line |
| 01/08/2008 | CA2319777C Dideoxy dye terminators |
| 01/08/2008 | CA2319757C Method for detection of nucleic acid target sequences involving in vitro transcription from an rna promoter |
| 01/08/2008 | CA2271929C Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 01/08/2008 | CA2248792C Methods for measurement of lymphocyte function |
| 01/08/2008 | CA2245261C Method for measuring ldl-cholesterol |
| 01/08/2008 | CA2210354C Mutant luciferases |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/03/2008 | WO2008003053A2 Minimizing effects of dye crosstalk |
| 01/03/2008 | WO2008002920A2 Methods for generating target nucleic acid sequences |
| 01/03/2008 | WO2008002882A2 Device and method for extraction and analysis of nucleic acids from biological samples |
| 01/03/2008 | WO2008002740A2 Methods, compositions, and kits for rna extraction |
| 01/03/2008 | WO2008002725A2 Purification and amplification of nucleic acids in a microfluidic device |
| 01/03/2008 | WO2008002680A2 A method of modifying a macromolecule without prior extraction from a sample |
| 01/03/2008 | WO2008002672A2 Targets for use in diagnosis, prognosis and therapy of cancer |
| 01/03/2008 | WO2008002668A2 Methods for arbitrary peptide synthesis |
| 01/03/2008 | WO2008002656A2 Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof |
| 01/03/2008 | WO2008002611A2 Delta-tocotrienol treatment and prevention of pancreatic cancer |
| 01/03/2008 | WO2008002605A2 Method and system for measuring single cell mechanics using a modified scanning probe microscope |
| 01/03/2008 | WO2008002502A2 Devices and systems for creation of dna cluster arrays |
| 01/03/2008 | WO2008002319A2 Compositions and methods for inhibition of retroviral infection |
| 01/03/2008 | WO2008002165A2 A method, assay and kit for prediction and treatment of a human subject infected with a virus |
| 01/03/2008 | WO2008002157A1 Apyrases and uses thereof |
| 01/03/2008 | WO2008002156A1 Mastitis and bacterial detection media |
| 01/03/2008 | WO2008001903A1 Fad-conjugated glucose dehydrogenase gene |
| 01/03/2008 | WO2008001888A1 Method for pre-treatment of serum for analysis of sugar chain |
| 01/03/2008 | WO2008001840A1 Method for diagnosis of kidney/urological disease |
| 01/03/2008 | WO2008001691A1 Method of treating sample |
| 01/03/2008 | WO2008001676A1 Lactic acid bacterium for amelioration of lactose intolerance |
| 01/03/2008 | WO2008001505A1 Composition for nucleic-acid introduction |
| 01/03/2008 | WO2008001504A1 Composition for nucleic acid delivery |
| 01/03/2008 | WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 01/03/2008 | WO2008001235A2 An in vitro method of detecting and/or diagnosing cancer using uv light based dna image cytometry |
| 01/03/2008 | WO2008001079A1 Methods for identifying modulators of eoxin formation |
| 01/03/2008 | WO2008001054A1 Pcr screening method |
| 01/03/2008 | WO2008000785A1 A screening method for identifying new drugs |
| 01/03/2008 | WO2008000770A1 Heated reaction chamber for processing a biochip and method for controlling said reaction chamber |
| 01/03/2008 | WO2008000767A1 Cooling device for a reaction chamber for processing a biochip and method for controlling said cooling device |
| 01/03/2008 | WO2008000749A1 Detection of esr1 amplification in breast cancer |
| 01/03/2008 | WO2008000734A1 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof |
| 01/03/2008 | WO2008000186A1 A method for identifying novel gene and the resulting novel genes |
| 01/03/2008 | WO2008000090A1 Dna barcode sequence classification |
| 01/03/2008 | WO2008000089A1 Method of detecting preeclampsia |
| 01/03/2008 | WO2008000060A1 Microfluidic methods for nucleic acid monitoring |
| 01/03/2008 | WO2008000023A1 Detection of influenza virus |
| 01/03/2008 | WO2007130951A3 Methods and apparatus for sequential amplification reactions |
| 01/03/2008 | WO2007126402A3 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 01/03/2008 | WO2007123772A3 Genes involved in estrogen metabolism |
| 01/03/2008 | WO2007106118A3 Aptamer-based colorimetric sensor systems |
| 01/03/2008 | WO2007092966A3 Methods and devices for the detection and measurement of free metals in fluids and methods for diagnosing metal-related diseases and for determining pharmacologic dosing regimens |
| 01/03/2008 | WO2007091056A3 Bicyclic compounds and their use |
| 01/03/2008 | WO2007090873B1 Oxidoreductases and processes utilising such enzymes |
| 01/03/2008 | WO2007087178A3 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 01/03/2008 | WO2007084855A3 Genetic markers for boar taint |
| 01/03/2008 | WO2007082881A8 Hybridization probe assay and array |
| 01/03/2008 | WO2007075967A3 Sequencing and genotyping using reversibly 2'-modified nucleotides |